
### [MONDO:0003072](http://purl.obolibrary.org/obo/MONDO_0003072)
**Label:** retinal cancer

**Subclasses:** [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0004349](http://purl.obolibrary.org/obo/MONDO_0004349) (retina lymphoma), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0004338](http://purl.obolibrary.org/obo/MONDO_0004338) (retinal cell cancer), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0004561](http://purl.obolibrary.org/obo/MONDO_0004561) (retinal melanoma), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), 

**Mapped go classes:** [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), 

**Class expressions from DL-Learner:**

- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 66.67%
- [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance) 66.67%
- [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development) 66.67%
- Thing 51.11%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 34.49%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 32.48%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 31.10%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 31.10%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 20.82%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 19.99%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 19.47%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 19.33%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 19.26%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 18.96%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 18.65%


